Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L

PLoS Pathogens

Volumn 9, Issue 6, 2013, Pages

  Sorgeloos, Frédéric ^a   Jha, Babal Kant ^b   Silverman, Robert H ^b   Michiels, Thomas ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; RIBONUCLEASE L;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; VIRUS REPLICATION;

ANIMALS; CARDIOVIRUS INFECTIONS; CELL LINE; CRICETINAE; ENDORIBONUCLEASES; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MICE; MICE, MUTANT STRAINS; PROTEIN STRUCTURE, TERTIARY; SPECIES SPECIFICITY; THEILOVIRUS; VIRAL PROTEINS;

AVES; MAMMALIA; MURINAE; MUS; PICORNAVIRIDAE; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 84879534664     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003474     Document Type: Article

References (61)

1. Bisbal C, Silverman RH, (2007) Diverse functions of RNase L and implications in pathology. Biochimie 89: 789-798.
2. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR, (2006) Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80: 5059-5064.
3. Kerr IM, Brown RE, (1978) pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A 75: 256-260.
4. Dong B, Silverman RH, (1995) 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270: 4133-4137.
5. Dong B, Silverman RH, (1997) A bipartite model of 2-5A-dependent RNase L. J Biol Chem 272: 22236-22242.
6. Han Y, Whitney G, Donovan J, Korennykh A, (2012) Innate immune messenger 2-5A tethers human RNase L into active high-order complexes. Cell Rep 2: 902-913.
7. Malathi K, Dong B, Gale M Jr, Silverman RH, (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819.
8. Zhou A, Hassel BA, Silverman RH, (1993) Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72: 753-765.
9. Austin BA, James C, Silverman RH, Carr DJ, (2005) Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection. J Immunol 175: 1100-1106.
10. Zheng X, Silverman RH, Zhou A, Goto T, Kwon BS, et al. (2001) Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest Ophthalmol Vis Sci 42: 120-126.
11. Diaz-Guerra M, Rivas C, Esteban M, (1997) Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236: 354-363.
12. Flodstrom-Tullberg M, Hultcrantz M, Stotland A, Maday A, Tsai D, et al. (2005) RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 174: 1171-1177.
13. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, et al. (2006) PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 80: 7009-7019.
14. Cruz JL, Sola I, Becares M, Alberca B, Plana J, et al. (2011) Coronavirus gene 7 counteracts host defenses and modulates virus virulence. PLoS Pathog 7: e1002090.
15. Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, et al. (2012) Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology. Cell Host Microbe 11: 607-616.
16. Han JQ, Barton DJ, (2002) Activation and evasion of the antiviral 2′-5′ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA 8: 512-525.
17. Han JQ, Wroblewski G, Xu Z, Silverman RH, Barton DJ, (2004) Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites. J Interferon Cytokine Res 24: 664-676.
18. Han JQ, Townsend HL, Jha BK, Paranjape JM, Silverman RH, et al. (2007) A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J Virol 81: 5561-5572.
19. Townsend HL, Jha BK, Han JQ, Maluf NK, Silverman RH, et al. (2008) A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L. RNA 14: 1026-1036.
20. Martinand C, Salehzada T, Silhol M, Lebleu B, Bisbal C, (1998) RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. Eur J Biochem 254: 248-255.
21. Cayley PJ, Davies JA, McCullagh KG, Kerr IM, (1984) Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur J Biochem 143: 165-174.
22. Hersh CL, Brown RE, Roberts WK, Swyryd EA, Kerr IM, et al. (1984) Simian virus 40-infected, interferon-treated cells contain 2′,5′-oligoadenylates which do not activate cleavage of RNA. J Biol Chem 259: 1731-1737.
23. Rice AP, Kerr SM, Roberts WK, Brown RE, Kerr IM, (1985) Novel 2′,5′-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells. J Virol 56: 1041-1044.
24. Rice AP, Roberts WK, Kerr IM, (1984) 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication. J Virol 50: 220-228.
25. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, et al. (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30: 181-184.
26. Madsen BE, Ramos EM, Boulard M, Duda K, Overgaard J, et al. (2008) Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer. PLoS One 3: e2492.
27. Theiler M, Gard S, (1940) Encephalomyelitis of Mice: I. Characteristics and Pathogenesis of the Virus. J Exp Med 72: 49-67.
28. Lipton HL, Twaddle G, Jelachich ML, (1995) The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 69: 2525-2533.
29. Roussarie JP, Ruffie C, Brahic M, (2007) The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog 3: e23.
30. Michiels T, Roos R (2010) Theiler's Virus Central Nervous System Infection. In: Ehrenfeld E, Domingo E, Roos R, editors. The Picornaviruses. Washington: American Society for Microbiology. pp. 411-428.
31. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD, (2004) Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev 17: 174-207.
32. Ghadge GD, Ma L, Sato S, Kim J, Roos RP, (1998) A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol 72: 8605-8612.
33. Kong WP, Roos RP, (1991) Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol 65: 3395-3399.
34. van Eyll O, Michiels T, (2002) Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J Virol 76: 10665-10673.
35. Takata H, Obuchi M, Yamamoto J, Odagiri T, Roos RP, et al. (1998) L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J Virol 72: 4950-4955.
36. van Eyll O, Michiels T, (2000) Influence of the Theiler's virus L* protein on macrophage infection, viral persistence, and neurovirulence. J Virol 74: 9071-9077.
37. Obuchi M, Yamamoto J, Uddin N, Odagiri T, Iizuka H, et al. (1999) Theiler's murine encephalomyelitis virus (TMEV) subgroup strain-specific infection in neural and non-neural cell lines. Microbiol Immunol 43: 885-892.
38. Himeda T, Ohara Y, Asakura K, Kontani Y, Sawada M, (2005) A lentiviral expression system demonstrates that L* protein of Theiler's murine encephalomyelitis virus (TMEV) has an anti-apoptotic effect in a macrophage cell line. Microb Pathog 38: 201-207.
39. Sorgeloos F, Vertommen D, Rider MH, Michiels T, (2011) Theiler's virus L* protein is targeted to the mitochondrial outer membrane. J Virol 85: 3690-3694.
40. Silverman RH, (2007) Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81: 12720-12729.
41. Zhou A, Molinaro RJ, Malathi K, Silverman RH, (2005) Mapping of the human RNASEL promoter and expression in cancer and normal cells. J Interferon Cytokine Res 25: 595-603.
42. Jnaoui K, Michiels T, (1998) Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence. Virology 244: 397-404.
43. Thakur CS, Jha BK, Dong B, Das Gupta J, Silverman KM, et al. (2007) Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc Natl Acad Sci U S A 104: 9585-9590.
44. Himeda T, Okuwa T, Nojiri M, Muraki Y, Ohara Y, (2011) The anti-apoptotic protein L(*) of Theiler's murine encephalomyelitis virus (TMEV) contains a mitochondrial targeting signal. Virus Res 155: 381-388.
45. Obuchi M, Yamamoto J, Odagiri T, Uddin MN, Iizuka H, et al. (2000) L* protein of Theiler's murine encephalomyelitis virus is required for virus growth in a murine macrophage-like cell line. J Virol 74: 4898-4901.
46. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, et al. (1997) Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J 16: 6355-6363.
47. Azoulay-Cayla A, Dethlefs S, Perarnau B, Larsson-Sciard EL, Lemonnier FA, et al. (2000) H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. J Virol 74: 5470-5476.
48. Brahic M, Bureau JF, Michiels T, (2005) The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol 59: 279-298.
49. Lipton HL, Dal Canto MC, (1979) Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun 26: 369-374.
50. Nakanishi M, Goto Y, Kitade Y, (2005) 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L. Proteins 60: 131-138.
51. Min JY, Krug RM, (2006) The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103: 7100-7105.
52. Chiu CY, Greninger AL, Kanada K, Kwok T, Fischer KF, et al. (2008) Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci U S A 105: 14124-14129.
53. Jones MS, Lukashov VV, Ganac RD, Schnurr DP, (2007) Discovery of a novel human picornavirus in a stool sample from a pediatric patient presenting with fever of unknown origin. J Clin Microbiol 45: 2144-2150.
54. Zoll J, Erkens Hulshof S, Lanke K, Verduyn Lunel F, Melchers WJ, et al. (2009) Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life. PLoS Pathog 5: e1000416.
55. van Pesch V, van Eyll O, Michiels T, (2001) The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol 75: 7811-7817.
56. Michiels T, Dejong V, Rodrigus R, Shaw-Jackson C, (1997) Protein 2A is not required for Theiler's virus replication. J Virol 71: 9549-9556.
57. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L, (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25: 217-222.
58. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
59. Paul S, Michiels T, (2006) Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J Gen Virol 87: 1237-1246.
60. Rusch L, Dong B, Silverman RH, (2001) Monitoring activation of ribonuclease L by 2′,5′-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells. Methods Enzymol 342: 10-20.
61. Dong B, Xu L, Zhou A, Hassel BA, Lee X, et al. (1994) Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem 269: 14153-14158.